NCT00507936View on ClinicalTrials.gov

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Diabetic NeuralgiaDiabetic NeuropathiesDiabetic Neuropathy, PainfulDiabetic PolyneuropathyNeuralgia, Diabetic
Interventions
DRUG

ABT-894

ABT-894 1 mg capsule BID throughout treatment period

DRUG

ABT-894

ABT-894 2 mg capsule BID throughout treatment period

DRUG

ABT-894

ABT-894 4 mg capsule BID throughout treatment period

DRUG

placebo

placebo capsule BID throughout the treatment period

DRUG

Duloxetine

Duloxetine 60 mg QD throughout treatment period

Trial Locations (49)

10003

Site Reference ID/Investigator# 6045, New York

10022

Site Reference ID/Investigator# 5946, New York

10065

Site Reference ID/Investigator# 5216, New York

10115

Site Reference ID/Investigator# 6763, Berlin

10128

Site Reference ID/Investigator# 7483, New York

11108

Site Reference ID/Investigator# 5260, Narbonne

20132

Site Reference ID/Investigator# 5018, Milan

21122

Site Reference ID/Investigator# 6047, Pasadena

30029

Site Reference ID/Investigator# 7115, Nîmes

33012

Site Reference ID/Investigator# 6781, Hialeah

33418

Site Reference ID/Investigator# 7514, Palm Beach Gardens

33603

Site Reference ID/Investigator# 8113, Tampa

33765

Site Reference ID/Investigator# 5276, Clearwater

44223

Site Reference ID/Investigator# 6869, Cuyahoga Falls

44656

Site Reference ID/Investigator# 8427, Guadalajara

45138

Site Reference ID/Investigator# 7117, Essen

45245

Site Reference ID/Investigator# 5947, Cincinnati

58033

Site Reference ID/Investigator# 5171, Nevers

60596

Site Reference ID/Investigator# 5034, Frankfurt

63117

Site Reference ID/Investigator# 6043, St Louis

63141

Site Reference ID/Investigator# 6044, St Louis

68131

Site Reference ID/Investigator# 7906, Omaha

69120

Site Reference ID/Investigator# 6760, Heidelberg

72114

Site Reference ID/Investigator# 7387, North Little Rock

72205

Site Reference ID/Investigator# 5206, Little Rock

77074

Site Reference ID/Investigator# 7699, Houston

78218

Site Reference ID/Investigator# 5836, San Antonio

78229

Site Reference ID/Investigator# 5950, San Antonio

Site Reference ID/Investigator# 7187, San Antonio

85023

Site Reference ID/Investigator# 6053, Phoenix

85210

Site Reference ID/Investigator# 5207, Mesa

91106

Site Reference ID/Investigator# 5258, Corbeil-Essonnes

91950

Site Reference ID/Investigator# 8286, National City

92104

Site Reference ID/Investigator# 7696, Nanterre

92801

Site Reference ID/Investigator# 6052, Anaheim

92845

Site Reference ID/Investigator# 7064, Garden Grove

97239

Site Reference ID/Investigator# 5217, Portland

98104

Site Reference ID/Investigator# 6054, Seattle

02301

Site Reference ID/Investigator# 5277, Brockton

78229-4801

Site Reference ID/Investigator# 5899, San Antonio

K7L 1G1

Site Reference ID/Investigator# 8508, Kingston

H7T 2P5

Site Reference ID/Investigator# 8436, Laval

R2V 4W3

Site Reference ID/Investigator# 8481, Winnipeg

D - 55116

Site Reference ID/Investigator# 6732, Mainz

00133

Site Reference ID/Investigator# 5006, Rome

C.P. 11650

Site Reference ID/Investigator# 8497, Mexico City

C.P. 64460

Site Reference ID/Investigator# 8125, Monterrey, N.L.

00717-2075

Site Reference ID/Investigator# 8120, Ponce

00907

Site Reference ID/Investigator# 8121, San Juan

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT00507936 - Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain | Biotech Hunter | Biotech Hunter